Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/HCTZ in Olmesartan Non-Responders
NCT00171015Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2004
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, open-label, single-arm trial of valsartan in hypertension (HTN), sponsored by Novartis. Primary endpoint: Change from baseline in diastolic blood pressure at 4 weeks. Started Dec 2004; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00171015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171015.